Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy.
Theodore S JennaroFang FangKelley M KidwellEllen M Lavoie SmithKiran VangipuramMonika L BurnessJennifer J GriggsCatherine Van PoznakDaniel F HayesN Lynn HenryDaniel Louis HertzPublished in: Breast cancer research and treatment (2020)
Pre-treatment vitamin D deficiency was associated with PN in women receiving weekly paclitaxel for breast cancer. Vitamin D deficiency may be an easily detected PN risk factor that could be resolved prior to treatment to prevent PN, avoid treatment disruptions, and improve treatment outcomes.